candesartan cilexetil has been researched along with Muscle Contraction in 3 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan cilexetil has shown potent and long-lasting antihypertensive effects in clinical trials and in several animal models of hypertension." | 4.80 | Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action. ( Inada, Y; Kanagawa, R; Misumi, Y; Naka, T; Nishikawa, K; Ojima, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishikawa, K | 3 |
| Inada, Y | 3 |
| Shibouta, Y | 2 |
| Wada, T | 2 |
| Ojima, M | 3 |
| Kubo, K | 2 |
| Naka, T | 3 |
| Noda, M | 1 |
| Sanada, T | 1 |
| Kohara, Y | 1 |
| Kanagawa, R | 1 |
| Misumi, Y | 1 |
1 review available for candesartan cilexetil and Muscle Contraction
| Article | Year |
|---|---|
Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Benzimida | 1999 |
2 other studies available for candesartan cilexetil and Muscle Contraction
| Article | Year |
|---|---|
Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compoun | 1994 |
Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethy
Topics: Adrenal Cortex; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihype | 1993 |